May 3 (Reuters) - Antengene Corporation Ltd 6996.HK :
* UNIT ENTERED INTO FRAMEWORK AGREEMENT WITH HANGZHOU
QIANTANG NEW
AREA ADMINISTRATIVE COMMITTEE
* AGREEMENT TO BUILD A DRUG DISCOVERY AND MANUFACTURING
CENTER FOR
ANTIBODY BIOLOGICS
* IN ADDITION, PROJECT IS ALSO EXPECTED TO RECEIVE A TOTAL
INVESTMENT IN RESEARCH AND DEVELOPMENT OF RMB700 MILLION
* FROM 2021 TO 2026, PROJECT WILL RECEIVE A PHASED
FIXED-ASSET
INVESTMENT RMB640 MILLION AND RMB160 MILLION FOR OTHER
EXPENDITURES
Source text for Eikon: ID:nHKS9wpFrM
Further company coverage: 6996.HK
((Reuters.Briefs@thomsonreuters.com;))